Yxgene

At YXgene, we are dedicated to simplifying manufacturing complexities by offering integrated platforms that expedite the development, manufacturing, and release of cell and gene therapies, as well as mRNA therapies, with enhanced efficiency and reliability. Our Solutions: Oncolytic Virus CDMO Solutions – We specialize in process development and cGMP manufacturing services for various oncolytic virus products, including adenovirus, poxvirus, herpesvirus, and Newcastle disease virus. Our flexible cGMP manufacturing platform is capable of meeting manufacturing demands of various scales. Plasmid & Nucleotides CDMO Solutions – Leveraging our extensive expertise, we provide tailored Plasmid & Nucleotides manufacturing solutions encompassing plasmid DNA services, mRNA, and circRNA from process development to large-scale cGMP manufacturing. Our Facility and Experience: In response to the increasing global demand, we have commenced the construction of a GMP manufacturing site in Shenzhen, Guangdong, China, boasting 7 GMP production lines and spanning m2. Additionally, a new site with m2 is scheduled to be operational by 2025 in Anji, Zhejiang. YXgene has facilitated over 10 IND approvals and 20 IND submissions for customers across the United States, Europe, and the Asia Pacific region since October 2015. For further details, please visit our website or reach out via email at bd@yxgene.com.